This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations of Madhumita Mandal in Anti-Inflammatory Research
Introduction
Madhumita Mandal is a notable inventor based in West Bengal, India. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as inhibitors for various inflammatory diseases. Her work focuses on creating effective solutions for preventing gastric ulcers.
Latest Patents
Madhumita Mandal holds a patent for her invention titled "3-indolyl furanoids as inhibitors of matrix metalloproteinase-9 for prevention of gastric ulcer and other inflammatory diseases." This patent discloses 3-indolyl furanoid compounds that act as potent anti-inflammatory agents. These compounds prevent gastric ulcers by inhibiting the expression of matrix metalloproteinase-9 (MMP-9) in the gastric mucosal layer. The patent details various embodiments of these compounds, including a specific compound of formula 1, which features substituents with alkyl, aryl, and heteroaryl groups. Notably, one embodiment demonstrates an IC50 value of 50 µM for one of the 3-indolyl furanoids.
Career Highlights
Madhumita Mandal is affiliated with the Council of Scientific and Industrial Research, where she continues her research and development efforts. Her work has garnered attention for its potential applications in treating diseases associated with gastric ulcers and other inflammatory conditions.
Collaborations
Madhumita has collaborated with esteemed colleagues, including Parasuraman Jaisankar and Snehasikta Swarnakar, who contribute to her research endeavors.
Conclusion
Madhumita Mandal's innovative work in the field of anti-inflammatory research highlights her commitment to developing effective treatments for gastric ulcers and related diseases. Her contributions are paving the way for advancements in medicinal chemistry and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
